Exchange: NASDAQ·Updated 06:49 PM EDT
RCKT logo

RCKT Rocket Pharmaceuticals Inc

$3.70
$0.12
(3.17%)
Today
Closed $3.66
$0.04
(1.09%)
After Hours
Reported EarningsAug 10
Mkt Cap$414.95M
Vol1.12M

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. The firm's multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
61

Bullish Sentiment

How do you feel about RCKT?

Advertisement|Remove ads.